S100鈣結(jié)合蛋白A2(S100A2)多克隆抗體
Polyclonal Antibody to S100 Calcium Binding Protein A2 (S100A2)
S100-A2; CAN19; S100L
- 編號PAC009Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPC009Hu02-S100鈣結(jié)合蛋白A2(S100A2)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Skin cancer Tissue; Primary Ab: 10μg/ml Rabbit Anti-Human S100A2 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. DAB staining on IHC-P;
Samples: Human Kidney Tissue. -
DAB staining on IHC-P;
Sample: Human Skin cancer Tissue
Primary Ab: 10μg/ml Rabbit Anti-Human S100A2 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant S100A2, Human.
-
Western Blot; Sample: A431 cell lysate
Primary Ab: 5μg/ml Rabbit Anti-Human S100A2 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對S100A2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別S100A2。
用法
Western blotting: 0.5-5μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC009Hu02 | S100鈣結(jié)合蛋白A2(S100A2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC009Hu01 | S100鈣結(jié)合蛋白A2(S100A2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC009Hu02 | S100鈣結(jié)合蛋白A2(S100A2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC009Hu01 | S100鈣結(jié)合蛋白A2(S100A2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC009Hu81 | S100鈣結(jié)合蛋白A2(S100A2)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAC009Hu71 | S100鈣結(jié)合蛋白A2(S100A2)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAC009Hu22 | S100鈣結(jié)合蛋白A2(S100A2)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC009Hu21 | S100鈣結(jié)合蛋白A2(S100A2)單克隆抗體 | WB; IHC; ICC; IP. |
| SEC009Hu | S100鈣結(jié)合蛋白A2(S100A2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC009Hu | S100鈣結(jié)合蛋白A2(S100A2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Tumour Biol | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer [PubMed: 26361956] |
| Italian Journal of Cancer | S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusionS100A2: A potential biomarker to differentiate malignant from?… [] |
留言咨詢
